Gainers at Biotech: DARA Biosciences Inc (NASDAQ:DARA), Arrowhead Research Corp (NASDAQ:ARWR), Acasti Pharma Inc (NASDAQ:ACST), Neuralstem (NYSEMKT: CUR)

Posted by on Jul 10, 2014

On 17 JUNE DARA Biosciences Inc (NASDAQ:DARA) announced that its Board of Directors has appointed current President and Chief Operating Officer (COO) Christopher G. Clement to President and Chief Executive Officer (CEO), effective immediately. David J. Drutz, M.D., the Company’s current CEO and Chief Medical Officer (CMO), will transition to the Executive Chairman of the Board of Directors while continuing to serve as CMO. DARA Biosciences Inc (NASDAQ:DARA) weekly performance is 6.56%. On last trading day company shares ended up $1.30. Analysts mean target price for the company is $2.00. DARA Biosciences Inc (NASDAQ:DARA) distance from 50-day simple moving average (SMA50) is -0.94%.

On 20 JUNE Arrowhead Research Corp (NASDAQ:ARWR) reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by $0.11. Analysts expect that Arrowhead Research Corp will post $-0.92 EPS for the current fiscal year. Arrowhead Research Corp (NASDAQ:ARWR) shares advanced 8.07% in last trading session and ended the day on $12.32. ARWR return on assets is -47.50%. Arrowhead Research Corp (NASDAQ:ARWR) quarterly performance is -24.83%.

On 16 JUNE Acasti Pharma Inc (NASDAQ:ACST) announced that Xavier Harland resigned as the company’s Chief Financial Officer, effective immediately. Acasti Pharma Inc (NASDAQ:ACST) shares moved up 7.57% in last trading session and was closed at $1.08, while trading in range of $1.05 – $1.22. Acasti Pharma Inc (NASDAQ:ACST) year to date (YTD) performance is -13.60%.

On 26 JUNE Neuralstem, Inc. (NYSEMKT: CUR) reported ($0.07) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.06) by $0.01. The company had revenue of $0.00 million for the quarter, compared to the consensus estimate of $0.35 million. On average, analysts predict that Neuralstem will post $-0.25 earnings per share for the current fiscal year. Neuralstem, Inc. (NYSEMKT: CUR) ended the last trading day at $3.56. Company weekly volatility is calculated as 6.73% and price to cash ratio as 9.28. Neuralstem, Inc. (NYSEMKT: CUR) showed a negative weekly performance of -11.22%.

Leave a Reply

Your email address will not be published. Required fields are marked *